Serum Level of Ligand Programmed Death-1 in Endometriosis

Lyudmila Akhmaltdinova; Leila Appazova; Yasminur Turdybekova; Irina Kopobayeva; Zhanna Amirbekova; Igor Marinkin

doi:10.3889/oamjms.2022.8733

Authors

Lyudmila Akhmaltdinova Collective Use Laboratory, Research Center, Non-commercial Joint-stock Company “Karaganda Medical University,” Karaganda, Kazakhstan https://orcid.org/0000-0001-5602-6136
Leila Appazova Collective Use Laboratory, Research Center, Non-commercial Joint-stock Company “Karaganda Medical University,” Karaganda, Kazakhstan https://orcid.org/0000-0001-8742-6300
Yasminur Turdybekova Department of Obstetrics, Gynecology and Perinatology, Non-commercial Joint-stock Company “Karaganda Medical University,” Karaganda, Kazakhstan https://orcid.org/0000-0001-8742-6300
Irina Kopobayeva Department of Obstetrics, Gynecology and Perinatology, Non-commercial Joint-stock Company “Karaganda Medical University,” Karaganda, Kazakhstan https://orcid.org/0000-0001-8742-6300
Zhanna Amirbekova Department of Obstetrics, Gynecology and Perinatology, Non-commercial Joint-stock Company “Karaganda Medical University,” Karaganda, Kazakhstan https://orcid.org/0000-0003-4254-1094
Igor Marinkin Department of Obstetrics and Gynecology, Novosibirsk State Medical University, Novosibirsk, Russian Federation https://orcid.org/0000-0002-9409-4823

DOI:

https://doi.org/10.3889/oamjms.2022.8733

Keywords:

Endometriosis, Ligand programmed death-1, Cancer antigen 125, Interleukin-6, Interleukin-8, Tumor necrosis factor, Vascular endothelial growth factor, Cytokines

Abstract

AIM: In this study, is to evaluate serum level of ligand programmed death-1 (PDL1) in patients with genital endometriosis.

MATERIAL AND METHODS: For PDL-1, cancer antigen 125 (CA 125), interleukin (IL)-6, IL-8, tumor necrosis factor (TNF), and vascular endothelial growth factor (VEGF) determination, venous blood was taken 1 h before surgery and/or treatment. All patients were stratified by the presence or absence of endometriosis according to the American Society of Reproductive Medicine’s Revised Classification of Endometriosis of the American Society of Reproductive Medicine.

RESULTS: Twenty-one patients with endometriosis participated in the study. The PDL-1 level an experienced group was 55.32 ng/ml (interquartile range [IQR] 34.53–76.20); in the control group was 19.72 ng/ml (IQR 14.72–24.78), which was a statistically significant decrease (p < 0.001). A significant increase in CA125 31.87 (IQR 15.43–36.96) was detected (p < 0.001). In the experimental group, all pro-inflammatory cytokines were elevated (IL-6, IL-8, and TNF, p < 0.013; <0.001; and <0.001) and almost twice increased VEGF 243.44 (IQR 194.56–328.07), (p = 0.016). A noticeable correlation was found between the following indicators PDL-1-CA125, PDL-1-IL-8, and PDL-1-TNF, and a moderate correlation was found between PDL-1 and VEFF (p = 0.006).

CONCLUSIONS: The results of the study showed that the levels of PDL-1, CA 125, IL-6, IL-8, TNF, and VEGF were statistically significantly different in the experimental and control groups, and a correlation was also revealed between the levels of PDL-1 and CA125, IL-8 and TNF in patients with genital endometriosis. Therefore, further studies with larger numbers of patients are required.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Prescott J, Farland LV, Tobias DK, Gaskins AJ, Spiegelman D, Chavarro JE, et al. A prospective cohort study of endometriosis and subsequent risk of infertility. Hum Reprod. 2016;31(7):1475-82. https://doi.org/10.1093/humrep/dew085 PMid:27141041 DOI: https://doi.org/10.1093/humrep/dew085

Tanbo T, Fedorcsak P. Endometriosis-associated infertility: Aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand. 2017;96(6):659-67. https://doi.org/10.1111/aogs.13082 PMid:27998009 DOI: https://doi.org/10.1111/aogs.13082

Hadisaputra W, Prayudhana S. Serum biomarker profiles of interleukin-6, tumor necrosis factor-alpha, matrix-metalloproteinase-2, and vascular endothelial growth factor in endometriosis staging. Med J Indones. 2013;22:76-82. DOI: https://doi.org/10.13181/mji.v22i2.532

Walankiewicz M, Grywalska E, Polak G, Korona-Glowniak I, Witt E, Surdacka A, et al. The increase of circulating PD-1- and PD-L1-expressing lymphocytes in endometriosis: Correlation with clinical and laboratory parameters. Mediat Inflamm. 2018;2018:7041342. https://doi.org/10.1155/2018/7041342 PMid:30595667 DOI: https://doi.org/10.1155/2018/7041342

Gao Y, Shi S, Ma W, Chen J, Cai Y, Ge L, et al. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer. Int Immunopharmacol. 2019;72:374-84. https://doi.org/10.1016/j.intimp.2019.03.045 PMid:31030093 DOI: https://doi.org/10.1016/j.intimp.2019.03.045

Riley JL. PD-1 signaling in primary T cells. Immunol Rev. 2009;229(1):114-25. https://doi.org/10.1111/j.1600-065X.2009.00767.x PMid:19426218 DOI: https://doi.org/10.1111/j.1600-065X.2009.00767.x

McKay JT, Egan RP, Yammani RD, Chen L, Shin T, Yagita H, et al. PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism. J Immunol. 2015;194(5):2289-99. https://doi.org/10.4049/jimmunol.1401673 PMid:25624454 DOI: https://doi.org/10.4049/jimmunol.1401673

Lim TS, Chew V, Sieow JL, Goh S, Yeong JP, Soon AL, et al. PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity. Oncoimmunology. 2016;5(3):e1085146. https://doi.org/10.1080/2162402X.2015.1085146 PMid:27141339 DOI: https://doi.org/10.1080/2162402X.2015.1085146

Barros IB, Malvezzi H, Gueuvoghlanian-Silva BY, Piccinato CA, Rizzo LV, Podgaec S. What do we know about regulatory T cells and endometriosis? A systematic review. J Reprod Immunol. 2017;120:48-55. https://doi.org/10.1016/j.jri.2017.04.003 PMid:28463710 DOI: https://doi.org/10.1016/j.jri.2017.04.003

Wu L, Lv C, Su Y, Li C, Zhang H, Zhao X, et al. Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol. Gynecol Endocrinol. 2019;35(3):251-6. https://doi.org/10.1080/09513590.2018.1519787 PMid:30325236 DOI: https://doi.org/10.1080/09513590.2018.1519787

Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, et al. The performance of CA-125 measurement in the detection of endometriosis: A meta-analysis. Fertil Steril. 1998;70(6):1101-8. https://doi.org/10.1016/s0015-0282(98)00355-0 PMid:9848302 DOI: https://doi.org/10.1016/S0015-0282(98)00355-0

Hirsch M, Duffy JM, Deguara CS, Davis CJ, Khan KS. Diagnostic accuracy of cancer antigen 125 (CA125) for endometriosis in symptomatic women: A multi-center study. Eur J Obstet Gynecol Reprod Biol. 2017;210:102-107. https://doi.org/10.1016/j.ejogrb.2016.12.002 PMid:27987404 DOI: https://doi.org/10.1016/j.ejogrb.2016.12.002

Karimi-Zarchi M, Dehshiri-Zadeh N, Sekhavat L, Nosouhi F. Correlation of CA-125 serum level and clinico-pathological characteristic of patients with endometriosis. Int J Reprod Biomed. 2016;14(11):713-8. PMid:28008424 DOI: https://doi.org/10.29252/ijrm.14.11.713

Mihalyi A, Gevaert O, Kyama CM, Simsa P, Pochet N, De Smet F, et al. Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod. 2010;25(3):654-64. https://doi.org/10.1093/humrep/dep425 PMid:20007161 DOI: https://doi.org/10.1093/humrep/dep425

Machairiotis N, Vasilakaki S, Thomakos N. Inflammatory mediators and pain in endometriosis: A systematic review. Biomedicines. 2021;9(1):54. https://doi.org/10.3390/biomedicines9010054 PMid:33435569 DOI: https://doi.org/10.3390/biomedicines9010054

Mckinnon B, Mueller MD, Nirgianakis K, Bersinger NA. Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125. Mol Med Rep. 2015;12(4):5179-84. https://doi.org/10.3892/mmr.2015.4062 PMid:26165164 DOI: https://doi.org/10.3892/mmr.2015.4062

Xavier P, Belo L, Beires J, Rebelo I, Martinez-de-Oliveira J, Lunet N, et al. Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet. 2006;273(4):227-31. https://doi.org/10.1007/s00404-005-0080-4 PMid:16208475 DOI: https://doi.org/10.1007/s00404-005-0080-4

Sbracia M, Valeri C, Antonini G, Biagiotti G, Pacchiarotti A, Pacchiarotti A. Fas and fas-ligand in eutopic and ectopic endometrium of women with endometriosis: The possible immune privilege of ectopic endometrium. Reprod Sci. 2016;23(1):81-6. https://doi.org/10.1177/1933719115594019 PMid:26156853 DOI: https://doi.org/10.1177/1933719115594019